アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/09 | 1,400 | 1,402.5 | 1,385 | 1,396 | -12 | -0.9% | 8,774,800 |
2025/05/08 | 1,431 | 1,434.5 | 1,399 | 1,408 | -23.5 | -1.6% | 5,653,800 |
2025/05/07 | 1,458.5 | 1,459.5 | 1,414 | 1,431.5 | -26.5 | -1.8% | 9,074,700 |
2025/05/02 | 1,438 | 1,464 | 1,434 | 1,458 | +19 | +1.3% | 5,931,000 |
2025/05/01 | 1,435.5 | 1,439.5 | 1,420.5 | 1,439 | +11.5 | +0.8% | 5,161,200 |
2025/04/30 | 1,433.5 | 1,446.5 | 1,419 | 1,427.5 | -7.5 | -0.5% | 9,544,200 |
2025/04/28 | 1,452 | 1,462 | 1,427.5 | 1,435 | +53.5 | +3.9% | 9,907,900 |
2025/04/25 | 1,374 | 1,388.5 | 1,366.5 | 1,381.5 | +21 | +1.5% | 5,515,400 |
2025/04/24 | 1,368 | 1,375 | 1,356 | 1,360.5 | -7.5 | -0.5% | 5,031,700 |
2025/04/23 | 1,377.5 | 1,378.5 | 1,357 | 1,368 | +18.5 | +1.4% | 4,657,900 |
2025/04/22 | 1,332.5 | 1,349.5 | 1,323.5 | 1,349.5 | +14 | +1% | 3,721,000 |
2025/04/21 | 1,348 | 1,348.5 | 1,327.5 | 1,335.5 | -17 | -1.3% | 3,499,900 |
2025/04/18 | 1,348 | 1,353 | 1,328.5 | 1,352.5 | +25.5 | +1.9% | 3,358,000 |
2025/04/17 | 1,321 | 1,328 | 1,314 | 1,327 | +4.5 | +0.3% | 3,912,800 |
2025/04/16 | 1,330 | 1,334.5 | 1,314.5 | 1,322.5 | -14.5 | -1.1% | 4,777,600 |
2025/04/15 | 1,332 | 1,350 | 1,328 | 1,337 | +24 | +1.8% | 5,711,400 |
2025/04/14 | 1,290 | 1,322.5 | 1,290 | 1,313 | +43.5 | +3.4% | 5,497,800 |
2025/04/11 | 1,253.5 | 1,276.5 | 1,251.5 | 1,269.5 | -64 | -4.8% | 10,637,500 |
2025/04/10 | 1,350 | 1,361 | 1,320.5 | 1,333.5 | +76.5 | +6.1% | 10,732,500 |
2025/04/09 | 1,328 | 1,331.5 | 1,243.5 | 1,257 | -84 | -6.3% | 13,738,400 |
2025/04/08 | 1,329.5 | 1,344 | 1,315 | 1,341 | +39.5 | +3% | 9,629,900 |
2025/04/07 | 1,300 | 1,337 | 1,274 | 1,301.5 | -88.5 | -6.4% | 11,695,000 |
2025/04/04 | 1,372 | 1,408 | 1,372 | 1,390 | +14.5 | +1.1% | 10,137,500 |
2025/04/03 | 1,375 | 1,388.5 | 1,365 | 1,375.5 | -28.5 | -2% | 11,161,900 |
2025/04/02 | 1,451 | 1,457 | 1,403 | 1,404 | -57 | -3.9% | 8,677,000 |
2025/04/01 | 1,461 | 1,473 | 1,454.5 | 1,461 | +14.5 | +1% | 5,137,800 |
2025/03/31 | 1,461 | 1,464 | 1,441.5 | 1,446.5 | -31 | -2.1% | 7,584,800 |
2025/03/28 | 1,468 | 1,482.5 | 1,467 | 1,477.5 | -25 | -1.7% | 7,099,200 |
2025/03/27 | 1,492 | 1,504 | 1,488.5 | 1,502.5 | +6.5 | +0.4% | 8,775,800 |
2025/03/26 | 1,510 | 1,512.5 | 1,490.5 | 1,496 | -4 | -0.3% | 6,444,400 |
2025/03/25 | 1,502 | 1,510 | 1,493.5 | 1,500 | -2 | -0.1% | 5,859,900 |
2025/03/24 | 1,506 | 1,512.5 | 1,502 | 1,502 | +8 | +0.5% | 5,173,300 |
2025/03/21 | 1,475 | 1,509 | 1,469.5 | 1,494 | +0.5 | ±0% | 13,285,100 |
2025/03/19 | 1,485 | 1,501 | 1,485 | 1,493.5 | +9.5 | +0.6% | 6,940,500 |
2025/03/18 | 1,492 | 1,495 | 1,484 | 1,484 | +4 | +0.3% | 5,453,700 |
2025/03/17 | 1,473.5 | 1,486 | 1,467 | 1,480 | +12 | +0.8% | 3,775,200 |
2025/03/14 | 1,446 | 1,472.5 | 1,446 | 1,468 | +9.5 | +0.7% | 6,953,100 |
2025/03/13 | 1,453 | 1,462.5 | 1,450 | 1,458.5 | +0.5 | ±0% | 4,370,200 |
2025/03/12 | 1,445.5 | 1,458 | 1,435 | 1,458 | +12 | +0.8% | 6,420,800 |
2025/03/11 | 1,455 | 1,463.5 | 1,443.5 | 1,446 | -14 | -1% | 8,560,400 |
2025/03/10 | 1,460 | 1,471 | 1,459 | 1,460 | +3.5 | +0.2% | 4,442,200 |
2025/03/07 | 1,458.5 | 1,468 | 1,452.5 | 1,456.5 | -15.5 | -1.1% | 7,105,700 |
2025/03/06 | 1,476 | 1,492 | 1,470.5 | 1,472 | +2 | +0.1% | 5,535,700 |
2025/03/05 | 1,457.5 | 1,484.5 | 1,454 | 1,470 | +12.5 | +0.9% | 6,518,800 |
2025/03/04 | 1,462.5 | 1,476.5 | 1,455 | 1,457.5 | -3.5 | -0.2% | 7,507,200 |
2025/03/03 | 1,470.5 | 1,474.5 | 1,455 | 1,461 | +7 | +0.5% | 4,600,600 |
2025/02/28 | 1,474.5 | 1,486 | 1,447 | 1,454 | -25 | -1.7% | 10,190,200 |
2025/02/27 | 1,487 | 1,500 | 1,477 | 1,479 | -10 | -0.7% | 4,382,200 |
2025/02/26 | 1,504 | 1,504.5 | 1,488.5 | 1,489 | -5.5 | -0.4% | 5,026,000 |
2025/02/25 | 1,466 | 1,498 | 1,466 | 1,494.5 | +29 | +2% | 5,199,200 |
1~
50
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム